Harman Finochem Ltd

Harman Finochem is an India-based pharmaceutical manufacturer and development partner that has served the industry since 1983. The company combines science-led development with a focus on quality, regulatory compliance and reliable supply. Its business spans active pharmaceutical ingredients (APIs), finished dosage formulations and contract development and manufacturing services.

Harman Finochem has developed more than 45 commercial APIs across key therapeutic areas. Its API facilities are described as compliant with US FDA, EU-GMP and PMDA requirements, and backward integration supports supply security. The company also produces oral solid dosage forms, including tablets, capsules and pellets, with technology transfer and validation capabilities.

Through its CDMO and CMO services, Harman Finochem supports customers from product development through commercial-scale manufacturing, offering flexible capacity and partnership for both global innovators and generic medicine companies. The company reports serving more than 75 countries, employing over 2,400 people and planning capacity of 10,800 metric tons. Its regulatory approvals and certifications span agencies and authorities in markets including the United States, European Union, Japan, Australia, Canada and Brazil.